ovarian hyperstimulation syndrome
Showing 1 - 25 of 44
Ovarian Hyperstimulation Syndrome, Infertility, Female Trial in Toronto (Pregnyl (1,500) IU, 1.5 mL of normal saline)
Recruiting
- Ovarian Hyperstimulation Syndrome
- Infertility, Female
- Pregnyl (1,500) IU
- 1.5 mL of normal saline
-
Toronto, Ontario, CanadaMount Sinai Hospital, Fertility Clinic
Dec 9, 2022
Live Birth Rate and Serum Progesterone During Hormonal
Completed
- Ovarian Hyperstimulation Syndrome
- Frozen-thawed Embryo Transfers
- Identification of predictive factors
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Oct 17, 2022
Ovarian Hyperstimulation Syndrome Trial in Banha (dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7
Suspended
- Ovarian Hyperstimulation Syndrome
- dydrgesterone 10 mg( tab)/12hs/14 days
- montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days
-
Banha, Qalyubiya, EgyptBanha University- Hawaa Fertility center
Sep 18, 2022
Freeze All Strategy Versus Fresh Embryo Transfer After GnRH
Completed
- Ovarian Hyperstimulation Syndrome
- Pregnancy Related
- obstetric outcomes after fresh versus cryopreserved embryo transfer
- (no location specified)
May 11, 2022
Ovarian Hyperstimulation Syndrome Trial (Calcium intravenous infsuion, 0.9 % saline)
Not yet recruiting
- Ovarian Hyperstimulation Syndrome
- Calcium intravenous infsuion
- 0.9 % saline
- (no location specified)
Feb 20, 2022
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome Trial in Tehran (Minimal ovarian stimulation)
Completed
- Polycystic Ovary Syndrome
- Ovarian Hyperstimulation Syndrome
- Minimal ovarian stimulation
-
Tehran, Iran, Islamic Republic ofRoyan Institute
Apr 18, 2021
Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome Trial in Be'er Ya'aqov (Synarel, 0.2 Mg/Inh Nasal Spray,
Recruiting
- Pregnancy Early
- +2 more
- Synarel, 0.2 Mg/Inh Nasal Spray
- +3 more
-
Be'er Ya'aqov, IsraelShamir Medical center
Mar 27, 2021
Ovarian Hyperstimulation Syndrome Trial in Potenza (recombinant LH)
Completed
- Ovarian Hyperstimulation Syndrome
- recombinant LH
-
Potenza, Basilicata, Italy
- +1 more
Nov 22, 2020
Medical Assistance for the Procreation and Risk of Thrombosis.
Terminated
- Ovarian Hyperstimulation Syndrome
- +2 more
- ovarian stimulation
-
Brest, France
- +8 more
Jul 8, 2020
Ovarian Hyperstimulation Syndrome Trial in Cairo (Fludrocortisone 0.1 Milligrams (mg), Bromocriptine)
Completed
- Ovarian Hyperstimulation Syndrome
- Fludrocortisone 0.1 Milligrams (mg)
- Bromocriptine
-
Cairo, Maadi, EgyptGanin Fertility Center
Apr 16, 2020
Ovarian Hyperstimulation Syndrome Trial in Cairo (Gonadotropin, Antagonist)
Completed
- Ovarian Hyperstimulation Syndrome
-
Cairo, Egypt
- +1 more
Nov 20, 2019
Ovarian Hyperstimulation Syndrome, Hypercoagulability Trial (COAGO)
Terminated
- Ovarian Hyperstimulation Syndrome
- Hypercoagulability
- COAGO
- (no location specified)
Oct 1, 2019
Endometrial Receptivity, Ovarian Hyperstimulation Syndrome Trial in Farmington (GnRH agonist, hCG)
Terminated
- Endometrial Receptivity
- Ovarian Hyperstimulation Syndrome
- GnRH agonist
- hCG
-
Farmington, ConnecticutUCHC Division of Reproductive Endocrinology
Oct 22, 2018
Ovarian Hyperstimulation Syndrome Trial in Farmington (hCG)
Completed
- Ovarian Hyperstimulation Syndrome
-
Farmington, ConnecticutUniversity of Connecticut Health Center
Sep 25, 2018
Ovarian Hyperstimulation Syndrome Trial in Singapore (Cabergoline, Placebo)
Completed
- Ovarian Hyperstimulation Syndrome
- Cabergoline
- Placebo
-
Singapore, SingaporeKK Women's and Children's Hospital
Aug 5, 2018
Ovarian Hyperstimulation Syndrome Trial in Cairo (Late Cabergoline 0.5mg, Early Cabergoline 0.5mg)
Unknown status
- Ovarian Hyperstimulation Syndrome
- Late Cabergoline 0.5mg
- Early Cabergoline 0.5mg
-
Cairo, EgyptIVF department in Kasr Alaini hospital,private IVF centre
Apr 8, 2018
Ovarian Hyperstimulation Syndrome, GnRH Antagonist, Aspirin Trial in Guangzhou (GnRH antagonist, aspirin)
Unknown status
- Ovarian Hyperstimulation Syndrome
- +4 more
- GnRH antagonist
- aspirin
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yatsen University
Jun 14, 2017
Ovarian Hyperstimulation Syndrome Trial in China (Triptorelin for Injection, Recombinant Human Choriogonadotropin alfa Solution
Unknown status
- Ovarian Hyperstimulation Syndrome
- Triptorelin for Injection
- +2 more
-
Hefei, Anhui, China
- +6 more
Feb 28, 2017
Ovarian Hyperstimulation Syndrome Trial in Madrid (hCG, triptorelin, Triptorelin, estradiol valerate, micronized vaginal
Completed
- Ovarian Hyperstimulation Syndrome
- hCG
- +4 more
-
Madrid, SpainInstituto Valenciano de Infertilidad
Oct 25, 2016
Ovarian Hyperstimulation Syndrome Trial in Guangzhou (bromocriptine, dexamethasone)
Unknown status
- Ovarian Hyperstimulation Syndrome
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital,Sun Yat-Sen University
Jul 24, 2016
Pregnancy, Ovarian Hyperstimulation Syndrome Trial in Antalya (final oocyte maturation trigger)
Withdrawn
- Pregnancy
- Ovarian Hyperstimulation Syndrome
- final oocyte maturation trigger
-
Antalya, TurkeyAntalya IVF
May 25, 2016
Ovarian Hyperstimulation Syndrome Trial in Inner Mongolia (Letrozole, Polygeline, Sodium Chloride)
Unknown status
- Ovarian Hyperstimulation Syndrome
- Letrozole
- +3 more
-
Inner Mongolia, ChinaThe Affiliated Hospital of Inner Mongolia Medical University
Feb 15, 2016
Infertility, Ovarian Hyperstimulation Syndrome, Quality of Life Trial in Dronninglund, Hvidovre (Patients receiving short
Completed
- Infertility
- +3 more
- Patients receiving short protocol IVF/ICSI-treatment.
- Long protocol
-
Dronninglund, Denmark
- +1 more
Jan 12, 2016
Ovarian Hyperstimulation Syndrome, Infertility Drugs, Female Trial (Delayed embryo transfer)
Withdrawn
- Ovarian Hyperstimulation Syndrome
- +2 more
- Delayed embryo transfer
- (no location specified)
Sep 3, 2015